Vinayak Doraiswamy Insider Trades
Chief Scientific OfficerChief Scientific Officer at AtriCure, Inc.. 1 significant open-market trade reported on SEC Form 4 in the last 180 days.
$0
Bought
$233K
Sold
0 / 1
Buys / Sells
1
Companies
Companies
- ATRCChief Scientific Officer
AtriCure, Inc.
1 sell, $233K
Reported Trades
Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.
| Filed | Company | Trade | Value |
|---|---|---|---|
| Jul 30, 2026 | ATRCChief Scientific Officer | sell6.5% of stake | $233K |
Other Insiders at These Companies
Everyone else who reported a significant open-market trade at the same company in the last 180 days. Several buyers inside one week is cluster buying.
- Regina E. GrovesDirector at ATRC1 sell, $288K
- Karl S. DahlquistChief Legal Officer at ATRC1 sell, $458K
- Sven WehrweinDirector at ATRC1 sell, $946K
- Justin J. NozneskyChief Mktg & Strategy Officer at ATRC1 sell, $240K
How to Read This Page
These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. Several insiders buying at the same company in the same week is cluster buying, the pattern the research literature rates highest. The window here is 180 days; the full filing history lives on EDGAR. This record has fewer than 2 trades under $500K, so it is not yet listed on the hub.
Get this insider's next buy the minute it files
InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.
Try free for 7 daysEvery call scored in public, misses included.